Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
Medtronic has introduced the FlexCath Advance Steerable Sheath, which facilitate easier access to reach the inferior veins of the heart when delivering and positioning the company's Arctic Front Advance Cryoballoon system in the left atrium ...
Tags: Medtronic, minimally invasive procedures, FlexCath sheath
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
Greenville, South Carolina, United States of America (Free-Press-Release.com) December 21, 2012 -- Chuck Gallagher, international Business Ethics expert was the featured keynote speaker at the Medtronic – Culture of Ethics and ...
Tags: Medtronic Culture, Ethics, Integrity, medical technology
Demand for real-time data, including personal health information, is driving the market for wearable, wireless devices that will grow from 14 million items this year to as many as 171 million in 2016. In four years, the market for ...
Medtronic has introduced remote monitoring CareLink Express Service, designed to obtain data regarding the status of the company's implanted cardiac devices. The US launch was based on the evaluation of CareLink Express Service in a ...
Tags: Cardiac Remote Monitoring System, Medtronic, medical equipement
Medtronic has gained CE mark for its Viva/Brava portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices. The family of CRT-Ds features a new algorithm, called AdaptivCRT, which by preserving patients' normal ...
Tags: Medtronic, CE mark, CRT-D devices, AdaptivCRT, CRT treatment
Medtronic has introduced the Endurant II AAA Stent Graft system in the US, following the US Food and Drug Administration's (FDA) approval. The Endurant II AAA Stent Graft system is designed for the treatment of abdominal aortic aneurysms ...
Tags: Medtronic, Endurant II AAA Stent Graft system, FDA, EVAR
Medtronic has completed enrolling patients in a clinical trial of its Amphirion drug-eluting balloon, designed to treat critical limb ischemia. The CE-marked Amphirion drug-eluting balloon features proprietary FreePac proprietary ...
Tags: Medtronic, clinical trial, limb ischemia, Amphirion drug-eluting balloon
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Medtronic, a provider of medical technology for use in imaging procedures, has launched a new MR-conditional pacing system in Japan. The new system, Advisa DR MRI SureScan, is designed to provide access to pacemaker patient's to have ...
Tags: Medtronic, medical technology, MR-conditional pacing system
Medtronic has treated the first US patient in a global, multicenter clinical trial, designed to compare the accuracy of its CoreValve system with surgical aortic valve replacement in treating patients with severe aortic stenosis and who are ...
Medtronic has purchased all the assets of China Kanghui, a provider of orthopedic devices, for $816m in cash. China Kanghui's new commercial products include trauma, spine and joint reconstruction, designed to improve health outcomes in ...
Tags: orthopedic devices, trauma, spine, joint reconstruction
Medtronic has introduced a new surgical procedure, designed for increasing volumetric area of the exiting nerve root and stabilizing the cervical spine in the US. Indirectly decompressing the neural foramen, the CERVICAL FACETLIFT ID/S ...
Tags: Medtronic, cervical surgical technique, biomechanical studies
The US Food and Drug Administration (FDA) has granted 510(k) approval to Medtronic's Aquamantys3 BSC 9.1S bipolar sealer with cutting, designed for use in orthopaedic surgery. By utilizing Transcollation technology, the BSC 9.1S Bipolar ...
Tags: FDA, 510(k)approval, orthopaedic surgery, transcollation technology